LASIK in Patients with Collagen Vascular Disease (CVD)

LASIK is laser eye surgery that reshapes the clear front window of the eye (the cornea) so you can see without glasses. A very thin flap is made on the surface, a laser reshapes the layer underneath, and the flap is laid back down. In people who have collagen vascular (autoimmune) diseases—such as rheumatoid arthritis, lupus, Sjögren’s syndrome, scleroderma, mixed connective tissue disease, ankylosing spondylitis and related conditions—the immune system is overactive. That can lead to dry eyes, slow healing, inflammation, and rare but serious corneal complications after surgery.

Collagen Vascular Disease (CVD) is a group of autoimmune diseases where the body’s defense system can attack tissues that contain collagen (including the eye surface). Common CVDs: rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), Sjögren’s syndrome (SS), scleroderma, and seronegative spondyloarthropathies. These conditions can cause dry eye, inflammation, delayed healing, and, in rare severe cases, corneal thinning/melt—all important for LASIK safety.

Historically, many device labels and guidance documents have listed autoimmune/collagen-vascular disease as a contraindication (a reason not to do LASIK). Newer expert discussions call it a relative contraindication in carefully selected patients whose disease is quiet and whose eyes are healthy and well-lubricated. Sjögren’s syndrome remains especially high-risk because of severe dry eye. Decisions are individualized and conservative. FDA Access DataPMC+1EyeWikiPubMed

---

Why extra caution is needed

• Autoimmune disease can slow or derail healing, making the LASIK flap and corneal surface more vulnerable.

• Dry eye is common in these conditions and LASIK can temporarily worsen dryness.

• Inflammation can flare, increasing risks like infection, haze, or (rarely) corneal melt.

• Some patients do well when the systemic disease is well controlled, there is no ocular involvement, and the ocular surface is optimized before surgery. Sjögren’s syndrome is usually a no for LASIK. AAOPMCReview of Optometry

---

Types

1) By condition

• Rheumatoid arthritis (RA). Can be considered only if RA is quiet, there is no history of corneal inflammation, and the ocular surface is healthy. Selected case series show acceptable outcomes under strict criteria. PMC

• Systemic lupus erythematosus (SLE). Similar to RA: possible only when quiescent and without ocular disease; careful screening is essential. PMC

• Sjögren’s syndrome. Typically not a candidate for LASIK because of severe aqueous-deficient dry eye and poor healing. PMC

• Scleroderma, mixed connective tissue disease, seronegative spondyloarthropathies (e.g., ankylosing spondylitis, psoriatic arthritis). Individualized; proceed only with quiescent disease and a pristine ocular surface. PMC

2) By surgical approach (context for CVD patients)

• Microkeratome LASIK vs femtosecond LASIK. Femtosecond flaps are more precise and may reduce flap-related trauma compared with older blades, but dryness and healing concerns remain driven by the patient’s disease. EyeWiki

• Surface ablation (PRK/LASEK) and SMILE (small-incision lenticule extraction). These alternatives avoid a large corneal flap and may be kinder to corneal nerves and the tear film. Some studies suggest less postoperative dry eye with SMILE (especially early on), though by 12 months the difference may shrink; surface procedures can also be reasonable if the ocular surface is optimized. These are still approached cautiously in autoimmune disease. Lippincott JournalsPMCModern Optometry

3) By disease control

• Active disease (recent flares, ongoing inflammation, or significant dry eye): do not proceed.

• Quiescent disease (stable ≥6–12 months, minimal medications, no ocular involvement, healthy tear film): consider only after exhaustive screening and detailed informed consent. EyeWiki+1

---

Causes

Each “cause” below is a plain-English reason complications are more likely in LASIK when you have a collagen vascular disease. Some overlap—real life biology is messy—but listing them separately helps you see the full picture.

1. Immune over-activity. Autoimmune systems can attack healthy tissues and over-react to surgical injury, disturbing normal corneal healing. PMC

2. Poor wound healing. Many device labels warn about abnormal healing in collagen vascular disease; cuts and laser ablations may take longer to seal and smooth. FDA Access Data

3. Aqueous-deficient dry eye (especially Sjögren’s). Tears are too few, so the surface lacks moisture and growth factors needed for re-epithelialization. LASIK can worsen dryness, especially in the early months. PMCLippincott Journals

4. Meibomian gland dysfunction. Thickened or blocked oil glands make tears evaporate quickly, destabilizing the tear film after surgery. ascrs.org

5. Goblet cell loss and mucin deficiency. Autoimmune inflammation can reduce mucin-producing cells, making the tear layer patchy and fragile. ascrs.org

6. Corneal nerve changes. LASIK severs some corneal nerves; autoimmune disease may already reduce nerve health, so sensation and reflex tearing can drop further. Lippincott Journals

7. Surface inflammation. Inflamed ocular surfaces overexpress inflammatory markers (e.g., MMP-9), correlating with staining and symptoms. Surgery on an inflamed surface increases risk. ascrs.org

8. Risk of corneal melt in select diseases (e.g., RA). Rare but devastating keratolysis has been reported in autoimmune patients after corneal surgery, so surgeons stay very cautious. AAO

9. Peripheral ulcerative keratitis tendency. Some CVDs predispose to peripheral corneal ulcers; LASIK cuts can stress the cornea and trigger edge problems. AAO

10. Ectasia risk if screening misses subtle weaknesses. All LASIK candidates face ectasia risk if hidden keratoconus exists; careful tomographic screening is crucial in every patient. NatureThe Open Ophthalmology Journal

11. Medication effects (steroids, immunosuppressants). These can mask infection, alter healing, or increase susceptibility to microbes. Decision-making must weigh doses and timing. PMC

12. Systemic flares. A body-wide autoimmune flare around the time of surgery can derail otherwise good healing. PMC

13. Eyelid disease and blinking issues. Inflammation of the lids (blepharitis) or incomplete blinking dries the surface and slows recovery. ascrs.org

14. Tear quality problems (osmolarity, stability). High osmolarity and fast breakup time mean a toxic, salty tear environment that irritates the healing epithelium. ascrs.org

15. Ocular surface disease (OSD) that is “silent.” Some patients feel fine but have staining on exam; operating without fixing this raises risk for fluctuating vision and discomfort. ascrs.org

16. Retinal or optic nerve involvement from autoimmune disease. If the back of the eye is affected (e.g., vasculitis, optic neuropathy), vision may not meet expectations even if the cornea heals well. EyeWiki

17. Contact-lens intolerance masking severe dry eye. Patients seeking LASIK to escape contact lens pain may actually have advanced dryness that needs treatment before any surgery. ascrs.org

18. Environmental stressors. Low humidity, air conditioning, screen time and CPAP can worsen postoperative dryness in already fragile eyes. Lippincott Journals

19. Abnormal epithelial basement membrane or micro-irregularities. Subtle surface disease increases risks like epithelial sloughing or poor flap adherence. Cleveland Clinic

20. Unrealistic expectations. When systemic disease limits comfort or stability, even a technically perfect LASIK may not deliver the “contact-lens-like” comfort the patient hopes for. Evidence-based counseling is key. Review of Ophthalmology

---

Symptoms

These are common complaints that either argue against having LASIK now (pre-op) or signal a problem after surgery. Any of these deserve careful evaluation.

1. Dryness and grittiness that worsens in the evening or with screens. Lippincott Journals

2. Burning or stinging in normal room air. Lippincott Journals

3. Fluctuating vision that clears after blinking or using drops. ascrs.org

4. Light sensitivity (photophobia) beyond what you expect. Lippincott Journals

5. Foreign-body sensation (“sand in the eyes”). Lippincott Journals

6. Redness that persists despite lubrication. Lippincott Journals

7. Night glare, halos, starbursts, especially if tear film is unstable. Lippincott Journals

8. Pain with eye movement or deep aching—think scleritis or severe surface disease; urgent assessment. AAO

9. Stringy mucus or filaments on the surface (sign of severe dryness). Lippincott Journals

10. Slow recovery of crisp vision after procedures or minor injuries. FDA Access Data

11. Recurrent erosions (episodes where the surface sticks to the eyelid and peels). Lippincott Journals

12. Contact lens intolerance long before surgery—often signals major dry eye. ascrs.org

13. Headaches or eye strain from unstable focusing due to tear film issues. Lippincott Journals

14. Reduced corneal sensation (eyes feel oddly “numb”), linked with neurotrophic dryness. Lippincott Journals

15. Unusual shadows or decreased contrast in patients with known retinal/optic nerve autoimmune involvement. EyeWiki

---

Diagnostic tests

Below are commonly used tests to decide if a patient with CVD is a safe refractive candidate and to monitor them after surgery. Each includes what it is, in very simple English, and why it matters.

Physical exam

1. Vision and refraction. Reading letters on a chart and measuring your glasses prescription. It shows your starting point and whether your vision fluctuates—a red flag for dryness. EyeWiki

2. Slit-lamp exam. A bright microscope lets the doctor look for staining, filaments, inflammation, and flap-relevant anatomy. It’s the foundation of pre-op safety. EyeWiki

3. Eyelid and meibomian gland exam. Gentle pressure expresses oil; thick toothpaste-like oil means poor tear quality and higher post-LASIK dryness risk. ascrs.org

4. Corneal sensation check (simple). A thin cotton thread or an esthesiometer touches the cornea to see if it feels normal—poor sensation predicts dry eye trouble. Lippincott Journals

Manual/office surface tests

5. Schirmer test (or phenol red thread). A tiny strip under the lower lid measures tear production. Low numbers warn of aqueous deficiency, common in Sjögren’s. ascrs.org

6. Tear breakup time (TBUT). Fluorescein dye shows how fast your tear film breaks up. Short times mean unstable tears and higher risk of blurry vision after LASIK. ascrs.org

7. Ocular surface staining (fluorescein/lissamine green). Dyes stick to damaged cells, revealing “map” patterns of dryness. Doctors aim to normalize staining before surgery. ascrs.org

8. Meibomian gland expression/quality grading. The doctor presses along the lid margin to score oil quality and flow; treatment is needed if poor. ascrs.org

9. Blink and exposure assessment. Incomplete blinks or wide exposure areas dry the surface; simple coaching or treatment can help before any refractive plan. ascrs.org

Lab and pathological tests

10. ANA panel (antinuclear antibodies). Helps confirm autoimmune activity level; if active, elective LASIK should wait. PMC

11. Rheumatoid factor and anti-CCP. Support RA diagnosis and activity; ocular complications from RA increase corneal risk. PMC

12. Anti-SSA/SSB (Ro/La). Marker for Sjögren’s syndrome, which is strongly linked to severe dry eye and poor LASIK candidacy. PMC

13. ESR/CRP. Inflammation markers; elevated levels suggest systemic activity—not the time for elective refractive surgery. PMC

14. Point-of-care MMP-9 (InflammaDry). A quick swab detects inflammatory enzyme on the ocular surface; doctors try to turn this negative before surgery. ascrs.org

Electrodiagnostic tests

15. Visual evoked potential (VEP) (select cases). Measures how well signals travel from eye to brain; useful if autoimmune disease may affect the optic nerve and visual potential. EyeWiki

16. Electroretinography (ERG) (select cases). Tests retinal function; if autoimmune disease affects the retina, refractive surgery may not deliver clear vision even with a perfect cornea. EyeWiki

Imaging tests

17. Corneal topography (Placido rings). Maps the front shape of the cornea to catch irregular patterns (e.g., early keratoconus) that raise ectasia risk. The Open Ophthalmology Journal

18. Corneal tomography (Scheimpflug; e.g., Pentacam). Maps front, back, and thickness profiles and calculates indices (e.g., Belin/Ambrósio BAD-D) to flag structural weakness. Essential for ectasia risk. NatureLippincott Journals

19. Epithelial thickness mapping (AS-OCT). Shows how the skin layer of the cornea redistributes to “hide” cone-shaped weaknesses. It can upgrade or downgrade candidacy. Cleveland Clinic

20. Meibography or in-vivo confocal microscopy (when available). Visualizes oil glands and corneal nerves; damage predicts dry eye symptoms and helps tailor treatment before any laser. Lippincott Journals

Non-pharmacological treatments

(Each item: what it is • purpose • how it helps)

1. Delay elective surgery until your disease is quiet • Purpose: lower immune activation risk • Mechanism: allows systemic and ocular inflammation to settle; reduces chance of corneal complications. Optical Express

2. Comprehensive ASCRS-style pre-op ocular surface workup (SPEED II, osmolarity, MMP-9, staining, topography/tomography, meibography) • Purpose: find hidden dry eye/blepharitis/EBMD • Mechanism: objective tests catch inflammation that could worsen after laser. ascrs.orgascrs.org

3. Lid hygiene & warm compresses • Purpose: treat meibomian gland dysfunction (MGD) • Mechanism: heat + massage liquefies meibum, improves oil layer, slows evaporation.

4. Environmental fixes (desktop humidifier, avoid direct AC/fans, blink breaks, 20-20-20 rule) • Purpose: reduce tear evaporation • Mechanism: more humidity + frequent blinking stabilizes film.

5. Digital ergonomics & blink training • Purpose: screen use reduces blink rate • Mechanism: conscious full blinks restore meibum/tear spread.

6. Contact lens holiday before measurements (often 1–2 weeks soft lenses; longer for RGPs) • Purpose: accurate topography/refraction • Mechanism: cornea returns to natural shape.

7. Non-preserved lubricants frequently (day) + gel at night • Purpose: reduce friction and staining • Mechanism: restores volume and protects epithelium.

8. Allergy control (non-med)—cool compresses, allergen avoidance • Purpose: cut histamine-driven inflammation • Mechanism: fewer mast-cell triggers → calmer surface.

9. Nutritional hydration • Purpose: support tear production • Mechanism: adequate water intake keeps mucins and aqueous layer healthier.

10. Smoking cessation • Purpose: smoking worsens dry eye and healing • Mechanism: reduces oxidative stress and vasoconstriction.

11. Eyelid margin exfoliation in-office (e.g., BlephEx) • Purpose: remove biofilm/Demodex debris • Mechanism: lowers bacterial load/toxins that destabilize tears.

12. Thermal pulsation / vectored heat treatments (e.g., LipiFlow/iLux/TearCare) • Purpose: rehabilitate MGD pre-op • Mechanism: heat+expression improves oil quality to stabilize tear film for accurate biometry and smoother recovery. Contentstack

13. Intense Pulsed Light (IPL) for rosacea-MGD • Purpose: reduce telangiectasias/inflammation • Mechanism: photocoagulates abnormal vessels → less cytokine spill-over to lids.

14. Punctal plugs (temporary collagen or silicone) • Purpose: keep natural tears longer • Mechanism: slows drainage → higher tear volume; often used after the surface is non-inflamed to avoid trapping inflammatory tears.

15. Moisture-chamber glasses • Purpose: decrease evaporation outdoors/AC • Mechanism: side shields create a humid micro-environment.

16. Scleral lenses or PROSE devices (if surgery is deferred) • Purpose: rehabilitate vision in severe dry eye or irregular cornea • Mechanism: fluid reservoir bathes cornea, can be an alternative to refractive surgery.

17. Treat blepharitis/Demodex at the root (tea tree oil wipes, lid scrubs) • Purpose: reduce mites/biofilm • Mechanism: less lid margin inflammation → steadier tears.

18. Optimize systemic disease with rheumatology team • Purpose: fewer flares around surgery • Mechanism: coordinated care keeps immune activity low. (Central principle from autoimmune refractive literature.) PMC

19. Procedure selection (SMILE or PRK instead of LASIK) • Purpose: reduce early neurotrophic dry eye (SMILE) or avoid a flap (PRK) • Mechanism: SMILE spares more nerves initially; PRK avoids flap-related issues (at cost of slower healing). PMCReview of Ophthalmology

20. Realistic counseling & consent • Purpose: align expectations • Mechanism: explains that dry eye may temporarily worsen and that extra visits/treatments may be needed; notes FDA-style contraindications for certain diseases/meds. U.S. Food and Drug Administration

---

Drug treatments

(Exact choices vary widely. Your surgeon will tailor to your disease, tear tests, and current medications.)

1. Preservative-free artificial tears • Class: lubricants • Dosing: 4–8×/day or more; gel at night • Purpose: comfort, reduce friction • Mechanism: replaces tear volume, protects epithelium • S/E: temporary blur, rare allergy.

2. Topical cyclosporine (0.05%–0.1%, e.g., cyclosporine A) • Class: calcineurin inhibitor • Dosing: 1 drop BID (effects build over 1–3 months) • Purpose: reduce inflammation, increase natural tear production • Mechanism: T-cell modulation at lacrimal glands and ocular surface • S/E: burning on instillation; rare infection reactivation—screen with your doctor. (Dry-eye PPP cautions that keratorefractive surgery can worsen dry eye; anti-inflammatories are standard tools.) AAO

3. Lifitegrast 5% • Class: LFA-1/ICAM-1 inhibitor • Dosing: 1 drop BID • Purpose: symptom/sign relief in inflammatory dry eye pre-/post-op • Mechanism: blocks T-cell adhesion • S/E: dysgeusia (taste), irritation, transient blur.

4. Short course soft steroid (e.g., loteprednol 0.5%) • Class: corticosteroid • Dosing: QID ×1–2 weeks then taper • Purpose: calm surface inflammation before surgery or during flares • Mechanism: broad cytokine suppression • S/E: IOP rise, cataract risk with long use—monitor.

5. Autologous serum tears (ASEDs) (20–50%) • Class: biologic tear substitute • Dosing: typically QID–Q2H for severe disease • Purpose: growth factors for severe dry eye, persistent epithelial defects • Mechanism: patient’s own serum provides epitheliotrophic factors (EGF, vitamin A, cytokines) • S/E: refrigeration/freezer logistics; infection control. (Evidence supports benefit in moderate-to-severe DED; quality of evidence varies). AAOPMC+1

6. Doxycycline (or azithromycin) for MGD • Class: tetracycline antibiotic (anti-inflammatory) • Dosing: doxy 50 mg BID (or 100 mg daily) for weeks; pulsed azithromycin regimens vary • Purpose: improve oil quality • Mechanism: inhibits matrix metalloproteinases, reduces lid inflammation • S/E: GI upset, photosensitivity; avoid in pregnancy.

7. Topical azithromycin 1% (where available) • Class: macrolide • Dosing: per label (often BID ×2 days, then daily ×12 days) • Purpose: MGD control • Mechanism: antimicrobial + anti-inflammatory • S/E: irritation.

8. Tacrolimus ointment (off-label to lid skin) • Class: calcineurin inhibitor • Dosing: thin film to lids once/twice daily under medical supervision • Purpose: atopic/rosacea lid inflammation control • Mechanism: T-cell modulation • S/E: stinging, sun sensitivity.

9. Oral secretagogues (pilocarpine 5 mg TID–QID or cevimeline 30 mg TID) • Class: cholinergic agonists • Purpose: Sjögren’s mouth/eye dryness • Mechanism: stimulates exocrine secretion • S/E: sweating, flushing, urinary frequency—do not use without physician clearance.

10. Prophylactic post-op antibiotic (per surgeon’s protocol) • Class: topical fluoroquinolone or equivalent • Dosing: short course • Purpose: prevent infection while epithelium heals • Mechanism: bactericidal • S/E: irritation, rare allergy.

About omega-3 fish oil capsules: Big RCTs (DREAM) did not show a clear benefit over placebo in dry eye symptoms/signs; some clinicians still use them selectively. Discuss with your surgeon before starting. New England Journal of MedicineAAO

---

Dietary, molecular & supportive supplements

(typical amounts shown are common practice ranges; always clear with your doctors—especially if you’re on blood thinners or immunomodulators)

1. Omega-3 (EPA/DHA): 1000–2000 mg/day combined. Function: anti-inflammatory lipid mediators; Mechanism: may shift eicosanoid balance. Evidence mixed (DREAM negative); consider if MGD-predominant and if your doctor agrees. New England Journal of Medicine

2. Vitamin D3: 1000–2000 IU/day (adjust to labs). Function: immune modulation; Mechanism: supports mucosal immunity.

3. Vitamin A (dietary focus; avoid excess supplements): aim for food sources (liver rarely; carrots, leafy greens). Function: epithelial health; Mechanism: goblet cell support. (Topicals/serum tears also supply vitamin A.)

4. GLA (gamma-linolenic acid, evening primrose/borage): 240–320 mg/day GLA. Function: may support tear film via anti-inflammatory prostaglandins. Mechanism: converts to DGLA.

5. Flaxseed (ALA): 1–2 Tbsp ground/day or ALA capsules. Function: plant omega-3 precursor.

6. Curcumin (turmeric extract): 500–1000 mg/day with piperine. Function: systemic anti-inflammatory adjunct; Mechanism: NF-κB modulation.

7. N-acetylcysteine (NAC): 600–1200 mg/day. Function: mucolytic/antioxidant; Mechanism: reduces goblet cell toxicity, helpful in filamentary keratitis.

8. Lactoferrin: 100–250 mg/day. Function: tear protein support; Mechanism: antimicrobial/anti-inflammatory.

9. Hyaluronic acid (oral): per product. Function: joint + mucosal hydration support.

10. Probiotics (multi-strain): daily. Function: gut-immune axis; Mechanism: may reduce systemic inflammation that can influence ocular surface.

11. Zinc (with copper balance): 10–15 mg/day short-term. Function: immune/cofactor roles.

12. Magnesium glycinate: 100–200 mg/day. Function: helps sleep/nerve comfort; indirect benefits for eye surface routines at night.

13. Bilberry/anthocyanins: antioxidant support for ocular microcirculation.

14. L-carnitine: 500–1000 mg/day. Function: mitochondrial support; sometimes used in neuropathic discomfort.

15. Collagen peptides: 5–10 g/day. Function: connective tissue support; Mechanism: amino acid supply (general wellness; ocular data limited).

Note: Supplements are adjuncts, not substitutes for medical therapy. Check interactions (e.g., fish oil/GLA with anticoagulants).

---

Regenerative / stem-cell-type” options

1. Autologous serum tears (ASEDs) • What: your own blood serum diluted into eye drops • Why: provide growth factors for severe dry eye or persistent defects • Mechanism: EGF, vitamin A, fibronectin aid epithelium • Evidence: supportive but variable quality. AAO

2. Platelet-rich plasma (PRP) eye drops • What: platelet concentrate eye drops • Why: higher growth-factor mix than standard serum • Mechanism: PDGF/VEGF/TGF-β promote healing • Status: increasingly used off-label in severe ocular surface disease.

3. Amniotic membrane (cryopreserved or dehydrated) graft or inlay • What: biologic scaffold placed on eye • Why: quiets inflammation, speeds re-epithelialization after severe dry eye flares • Mechanism: heavy-chain hyaluronan/pentraxin 3 complex moderates scarring.

4. Cenegermin (recombinant human nerve growth factor) • What: FDA-approved for neurotrophic keratitis • Why: in select post-laser neurotrophic cases, may help corneal nerve healing • Mechanism: stimulates corneal nerve/epithelial recovery; use only for proper indications.

5. Limbal stem-cell–based therapies (CLET/SLET) • What: surgical stem-cell transplantation for limbal stem cell deficiency • Why: rebuilds corneal surface when native stem cells are lost • Mechanism: repopulates limbal niche; not routine for refractive surgery dryness—reserved for specific pathology.

6. Systemic biologic DMARDs (e.g., rituximab, abatacept, tocilizumab, belimumab as chosen by rheumatology) • What: targeted immune control of RA/SLE/etc. • Why: stable systemic disease lowers ocular risk around any elective surgery • Mechanism: pathway-specific immune modulation • Caveat: timing around surgery and infection risk must be co-managed by rheumatology.

---

Procedures/surgeries

1. SMILE (Small Incision Lenticule Extraction) • What: femtosecond laser removes a tiny lens-shaped piece through a small incision; no flap • Why: tends to cause less early dry eye vs. LASIK; fewer nerve fibers cut • Trade-offs: slower fine-tuning than LASIK; outcomes excellent in experienced hands. PMCReview of Ophthalmology

2. PRK (surface ablation: ASA/LASEK/epi-LASIK variants) • What: laser reshapes surface after removing epithelium; no flap • Why: avoids flap complications; sometimes favored when nerves/flap are a concern • Trade-offs: more discomfort and slower recovery than LASIK. AAO

3. Phakic ICL (implantable collamer lens) • What: a lens placed inside the eye without reshaping cornea • Why: avoids corneal nerves; useful for high prescriptions/thin corneas • Trade-offs: intraocular surgery risks (infection, cataract, pressure).

4. Punctal occlusion by cautery (permanent) • What: seals tear drains • Why: for severe aqueous deficiency when plugs keep falling out • Trade-offs: epiphora (tearing), must treat inflammation first.

5. Amniotic membrane placement (office or OR) • What: biologic bandage • Why: to heal a damaged ocular surface before any refractive procedure or after complications • Trade-offs: temporary blur while on the eye.

---

Prevention tips

1. Do not schedule elective laser surgery during systemic disease flares.

2. Disclose all medicines—especially isotretinoin or amiodarone, which many device labels list as contraindications. FDA Access Data

3. Treat dry eye/MGD first using the ASCRS algorithm; do not proceed until corneal staining is normalized. ascrs.org

4. Prefer SMILE/PRK over LASIK if you are borderline on dryness. PMC

5. Use non-preserved tears early and often around surgery as instructed.

6. Avoid eye rubbing (flap safety for LASIK; comfort for all methods).

7. Pause contact lenses as directed before testing and after surgery.

8. Control eyelid disease (blepharitis/Demodex/rosacea).

9. Hydration, humidifier, blink breaks, and no smoke exposure.

10. Keep close follow-up; report pain, light sensitivity, or vision drop urgently.

---

When to see a doctor urgently

• Severe pain, light sensitivity, or a sudden drop in vision at any time.

• Worsening redness, discharge, or non-healing erosions after surgery.

• Any new corneal haze, white spot, or ring (could be inflammatory or infectious keratitis).

• Signs of a rheumatologic flare (joints, skin, mouth, fatigue) around the time of eye surgery—coordinate with rheumatology immediately.

---

What to eat (and what to avoid)

Eat more of: oily fish (if your doctor okays it), leafy greens, colorful vegetables, legumes, whole grains, nuts/seeds (for ALA/GLA), citrus/berries, olive oil, and plenty of water. These foods supply antioxidants, vitamins A/C/E, and healthy fats that support mucosa and general healing.

Limit/avoid: ultra-processed foods, very high sugar spikes, excessive alcohol (dehydrates), smoking (vasoconstriction/oxidative stress), and any supplement your doctor asks you to stop before surgery (e.g., some blood-thinners, high-dose omega-3 if you’re on anticoagulants).

---

FAQs

1. Is LASIK absolutely forbidden if I have CVD?
   Not absolutely in every situation, but many device labels still list autoimmune/CVD as a formal contraindication. Some newer studies suggest it may be reasonable in well-controlled disease with a healthy ocular surface—yet risk remains higher than average. Shared decision-making is essential. FDA Access DataLippincott Journals

2. Is Sjögren’s an automatic “no”?
   Severe aqueous-deficient dry eye in Sjögren’s makes the risk of poor healing and pain high. Many surgeons recommend against LASIK and may suggest non-corneal or non-flap options (e.g., ICL, careful PRK/SMILE only if surface is fully optimized). PMC

3. Why do surgeons worry so much about dry eye?
   LASIK cuts corneal nerves under the flap, often worsening dryness early on; SMILE typically causes less early dryness but differences narrow by 12 months. In autoimmune dry eye, this matters even more. PMC

4. Is SMILE safer for me than LASIK?
   For dryness, often yes in the first months; but overall candidacy still depends on ocular surface health and disease control. Review of Ophthalmology

5. Is PRK safer than LASIK?
   PRK avoids a flap but has slower recovery and more discomfort. Choice depends on your tests and risk profile. AAO

6. What if my rheumatologic disease flares after surgery?
   Call both your surgeon and rheumatologist promptly. Inflammation can endanger healing; early treatment helps.

7. Can I have surgery while taking biologics?
   Sometimes, yes, with rheumatology coordination. Evidence is limited; plans are individualized.

8. How long should my disease be quiet before surgery?
   Many centers require ≥6–12 months of stability with no ocular surface inflammation. Optical Express

9. Are there tests that “clear” me for surgery?
   No single test. Surgeons use a bundle: symptoms (SPEED II), tear osmolarity, MMP-9, staining, topography/tomography, pachymetry, ±meibography; all should look healthy. ascrs.org

10. Do omega-3 supplements help?
    Large randomized trials (DREAM) did not show clear benefit over placebo for dry eye symptoms/signs, though some still use them selectively. New England Journal of Medicine

11. What about serum or PRP eye drops?
    Autologous serum drops can help moderate-to-severe dry eye and persistent defects; evidence generally supportive but mixed across studies. AAO

12. Which meds disqualify me?
    Labels often list isotretinoin and amiodarone as contraindicated; discuss timing/alternatives with your doctors. FDA Access Data

13. If LASIK is not ideal, can I still lose glasses?
    Yes—SMILE, PRK, or ICL may be options depending on tests and disease control.

14. How long will I need extra drops after surgery?
    Expect months of surface care (lubricants ± anti-inflammatories). Your plan is personalized.

15. What’s the single biggest success factor?
    A healthy ocular surface before surgery—and quiet systemic disease—make the biggest difference in outcomes. ascrs.org

 

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 10, 2025.